IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis
The IHOPE study (ChiCTR 2000031166) evaluated the efficacy and safety of iron polysaccharide complex (a novel oral trivalent iron preparation) in individuals receiving hemodialysis (HD) in China.
第一作者机构:[1]Shanghai Jiao Tong Univ, Affiliated Renji Hosp, Sch Med, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
Lu Renhua,Jin Haijiao,Cao Juan,et al.IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis[J].JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY.2024,35(10):doi:10.1681/ASN.2024sc43kb9s.
APA:
Lu Renhua,Jin Haijiao,Cao Juan,Li Hua,Wang Xiaoxia...&Ni Zhaohui.(2024).IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,35,(10)
MLA:
Lu Renhua,et al."IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis".JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 35..10(2024)